Suchergebnisse - "De Ryck, Iris"

PubPharm (5)

1

GMMA Technology for the Development of Safe Vaccines : Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

enthalten in: Infectious diseases and therapy | 2022

von De Ryck, I. | Sarakinou, E. | Nakakana, U. | +7

ErratumIn: Infect Dis Ther. 2022 Jun;11(3):1313. - PMID 35435576

2

GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

enthalten in: Infectious diseases and therapy | 2022

von De Ryck, I. | Sarakinou, E. | Nakakana, U. | +7

3

GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

enthalten in: Infectious diseases and therapy | 2022

von De Ryck, I. | Sarakinou, E. | Nakakana, U. | +7

4

GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

enthalten in: Infectious diseases and therapy | 2022

von De Ryck, I. | Sarakinou, E. | Nakakana, U. | +7

5

Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine : Results from a phase 2b randomized, placebo-controlled challenge study in adults

enthalten in: EClinicalMedicine | 2021

von Frenck, R. | Conti, V. | Ferruzzi, P. | +21

1
[1]